nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—CYP1A1—head and neck cancer	0.277	1	CbGaD
Daunorubicin—NR5A1—Vinblastine—head and neck cancer	0.209	0.376	CbGbCtD
Daunorubicin—ABCC6—Vinblastine—head and neck cancer	0.0797	0.143	CbGbCtD
Daunorubicin—ABCC10—Docetaxel—head and neck cancer	0.0502	0.0903	CbGbCtD
Daunorubicin—ABCB11—Vinblastine—head and neck cancer	0.0331	0.0595	CbGbCtD
Daunorubicin—CYP1B1—Docetaxel—head and neck cancer	0.0273	0.0491	CbGbCtD
Daunorubicin—ABCC1—Vinblastine—head and neck cancer	0.0235	0.0423	CbGbCtD
Daunorubicin—SLC22A2—Vinblastine—head and neck cancer	0.0213	0.0383	CbGbCtD
Daunorubicin—ABCC1—Docetaxel—head and neck cancer	0.0194	0.0349	CbGbCtD
Daunorubicin—ABCC2—Vinblastine—head and neck cancer	0.0174	0.0313	CbGbCtD
Daunorubicin—ABCG2—Fluorouracil—head and neck cancer	0.017	0.0306	CbGbCtD
Daunorubicin—ABCC2—Docetaxel—head and neck cancer	0.0143	0.0258	CbGbCtD
Daunorubicin—ABCG2—Docetaxel—head and neck cancer	0.013	0.0233	CbGbCtD
Daunorubicin—CYP3A5—Docetaxel—head and neck cancer	0.00718	0.0129	CbGbCtD
Daunorubicin—CYP1A2—Fluorouracil—head and neck cancer	0.007	0.0126	CbGbCtD
Daunorubicin—ABCB1—Vinblastine—head and neck cancer	0.00567	0.0102	CbGbCtD
Daunorubicin—ABCB1—Docetaxel—head and neck cancer	0.00467	0.00841	CbGbCtD
Daunorubicin—Recall phenomenon—Hydroxyurea—head and neck cancer	0.00386	0.0422	CcSEcCtD
Daunorubicin—CYP3A4—Vinblastine—head and neck cancer	0.0034	0.00612	CbGbCtD
Daunorubicin—Nail changes—Fluorouracil—head and neck cancer	0.00332	0.0363	CcSEcCtD
Daunorubicin—CYP3A4—Docetaxel—head and neck cancer	0.0028	0.00504	CbGbCtD
Daunorubicin—Nail changes—Docetaxel—head and neck cancer	0.0024	0.0262	CcSEcCtD
Daunorubicin—Radiation recall reaction (dermatologic)—Docetaxel—head and neck cancer	0.00212	0.0232	CcSEcCtD
Daunorubicin—Cardiotoxicity—Fluorouracil—head and neck cancer	0.00204	0.0224	CcSEcCtD
Daunorubicin—Recall phenomenon—Docetaxel—head and neck cancer	0.00201	0.0219	CcSEcCtD
Daunorubicin—Myelodysplastic syndrome—Docetaxel—head and neck cancer	0.00173	0.0189	CcSEcCtD
Daunorubicin—Electrocardiogram change—Fluorouracil—head and neck cancer	0.00169	0.0184	CcSEcCtD
Daunorubicin—Myelosuppression—Vinblastine—head and neck cancer	0.00157	0.0171	CcSEcCtD
Daunorubicin—Cardiotoxicity—Docetaxel—head and neck cancer	0.00148	0.0161	CcSEcCtD
Daunorubicin—Myelosuppression—Hydroxyurea—head and neck cancer	0.00143	0.0156	CcSEcCtD
Daunorubicin—Lung infiltration—Hydroxyurea—head and neck cancer	0.00143	0.0156	CcSEcCtD
Daunorubicin—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00121	0.0132	CcSEcCtD
Daunorubicin—TOP2B—hair follicle—head and neck cancer	0.0012	0.057	CbGeAlD
Daunorubicin—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00113	0.0123	CcSEcCtD
Daunorubicin—Pericarditis—Fluorouracil—head and neck cancer	0.00111	0.0122	CcSEcCtD
Daunorubicin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00111	0.0122	CcSEcCtD
Daunorubicin—Myelosuppression—Fluorouracil—head and neck cancer	0.00103	0.0112	CcSEcCtD
Daunorubicin—Bone marrow depression—Hydroxyurea—head and neck cancer	0.000992	0.0108	CcSEcCtD
Daunorubicin—Cardiomyopathy—Fluorouracil—head and neck cancer	0.000942	0.0103	CcSEcCtD
Daunorubicin—Local reaction—Fluorouracil—head and neck cancer	0.00087	0.00952	CcSEcCtD
Daunorubicin—Sinus tachycardia—Docetaxel—head and neck cancer	0.000863	0.00944	CcSEcCtD
Daunorubicin—Pericardial effusion—Docetaxel—head and neck cancer	0.000848	0.00927	CcSEcCtD
Daunorubicin—Extravasation—Vinblastine—head and neck cancer	0.000841	0.0092	CcSEcCtD
Daunorubicin—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00081	0.00886	CcSEcCtD
Daunorubicin—Cellulitis—Vinblastine—head and neck cancer	0.000807	0.00883	CcSEcCtD
Daunorubicin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000801	0.00876	CcSEcCtD
Daunorubicin—Nail disorder—Fluorouracil—head and neck cancer	0.000743	0.00812	CcSEcCtD
Daunorubicin—Chest tightness—Docetaxel—head and neck cancer	0.000742	0.00811	CcSEcCtD
Daunorubicin—Myelosuppression—Docetaxel—head and neck cancer	0.000742	0.00811	CcSEcCtD
Daunorubicin—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000722	0.00789	CcSEcCtD
Daunorubicin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.000716	0.317	CbGdCrCtD
Daunorubicin—Ulcer—Hydroxyurea—head and neck cancer	0.000708	0.00774	CcSEcCtD
Daunorubicin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.000703	0.312	CbGdCrCtD
Daunorubicin—YWHAG—parotid gland—head and neck cancer	0.000682	0.0323	CbGeAlD
Daunorubicin—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000682	0.00745	CcSEcCtD
Daunorubicin—NR5A1—lymphoid tissue—head and neck cancer	0.000664	0.0315	CbGeAlD
Daunorubicin—TOP2B—parotid gland—head and neck cancer	0.000657	0.0312	CbGeAlD
Daunorubicin—YWHAG—saliva-secreting gland—head and neck cancer	0.000653	0.031	CbGeAlD
Daunorubicin—ABCC6—connective tissue—head and neck cancer	0.000637	0.0302	CbGeAlD
Daunorubicin—TOP2B—saliva-secreting gland—head and neck cancer	0.000629	0.0299	CbGeAlD
Daunorubicin—Mucosal inflammation—Docetaxel—head and neck cancer	0.000628	0.00687	CcSEcCtD
Daunorubicin—Necrosis—Fluorouracil—head and neck cancer	0.000614	0.00671	CcSEcCtD
Daunorubicin—YWHAG—connective tissue—head and neck cancer	0.0006	0.0285	CbGeAlD
Daunorubicin—Deafness—Vinblastine—head and neck cancer	0.000596	0.00651	CcSEcCtD
Daunorubicin—CYP1B1—hair follicle—head and neck cancer	0.000592	0.0281	CbGeAlD
Daunorubicin—Haemorrhoids—Docetaxel—head and neck cancer	0.000591	0.00647	CcSEcCtD
Daunorubicin—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000585	0.00639	CcSEcCtD
Daunorubicin—TOP2B—connective tissue—head and neck cancer	0.000578	0.0274	CbGeAlD
Daunorubicin—Febrile neutropenia—Docetaxel—head and neck cancer	0.000578	0.00632	CcSEcCtD
Daunorubicin—Extravasation—Fluorouracil—head and neck cancer	0.000552	0.00604	CcSEcCtD
Daunorubicin—Nail disorder—Docetaxel—head and neck cancer	0.000536	0.00586	CcSEcCtD
Daunorubicin—NR5A1—head—head and neck cancer	0.000535	0.0254	CbGeAlD
Daunorubicin—ABCC1—hair follicle—head and neck cancer	0.000532	0.0253	CbGeAlD
Daunorubicin—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.000531	0.0058	CcSEcCtD
Daunorubicin—Cellulitis—Fluorouracil—head and neck cancer	0.00053	0.00579	CcSEcCtD
Daunorubicin—POR—parotid gland—head and neck cancer	0.000518	0.0246	CbGeAlD
Daunorubicin—Liver disorder—Docetaxel—head and neck cancer	0.00051	0.00558	CcSEcCtD
Daunorubicin—Ulcer—Fluorouracil—head and neck cancer	0.000509	0.00557	CcSEcCtD
Daunorubicin—YWHAG—trachea—head and neck cancer	0.000504	0.0239	CbGeAlD
Daunorubicin—POR—saliva-secreting gland—head and neck cancer	0.000496	0.0236	CbGeAlD
Daunorubicin—TOP2B—trachea—head and neck cancer	0.000485	0.023	CbGeAlD
Daunorubicin—Dermatitis contact—Fluorouracil—head and neck cancer	0.000476	0.00521	CcSEcCtD
Daunorubicin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.000452	0.2	CbGdCrCtD
Daunorubicin—Angina pectoris—Vinblastine—head and neck cancer	0.000449	0.00491	CcSEcCtD
Daunorubicin—Necrosis—Docetaxel—head and neck cancer	0.000443	0.00485	CcSEcCtD
Daunorubicin—Oesophagitis—Fluorouracil—head and neck cancer	0.00044	0.00481	CcSEcCtD
Daunorubicin—YWHAG—lymphoid tissue—head and neck cancer	0.000439	0.0208	CbGeAlD
Daunorubicin—Pancytopenia—Vinblastine—head and neck cancer	0.000437	0.00478	CcSEcCtD
Daunorubicin—Rigors—Docetaxel—head and neck cancer	0.000426	0.00466	CcSEcCtD
Daunorubicin—ABCC6—thyroid gland—head and neck cancer	0.000423	0.0201	CbGeAlD
Daunorubicin—TOP2B—lymphoid tissue—head and neck cancer	0.000423	0.0201	CbGeAlD
Daunorubicin—ABCC10—parotid gland—head and neck cancer	0.000411	0.0195	CbGeAlD
Daunorubicin—Depression—Vinblastine—head and neck cancer	0.000409	0.00448	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000405	0.00443	CcSEcCtD
Daunorubicin—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000404	0.00442	CcSEcCtD
Daunorubicin—Myocardial infarction—Vinblastine—head and neck cancer	0.000402	0.0044	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000402	0.0044	CcSEcCtD
Daunorubicin—Pancytopenia—Hydroxyurea—head and neck cancer	0.000399	0.00436	CcSEcCtD
Daunorubicin—Extravasation—Docetaxel—head and neck cancer	0.000399	0.00436	CcSEcCtD
Daunorubicin—YWHAG—thyroid gland—head and neck cancer	0.000398	0.0189	CbGeAlD
Daunorubicin—ABCC10—saliva-secreting gland—head and neck cancer	0.000394	0.0187	CbGeAlD
Daunorubicin—Chest discomfort—Docetaxel—head and neck cancer	0.000393	0.0043	CcSEcCtD
Daunorubicin—Dysuria—Hydroxyurea—head and neck cancer	0.000393	0.00429	CcSEcCtD
Daunorubicin—Neutropenia—Hydroxyurea—head and neck cancer	0.000393	0.00429	CcSEcCtD
Daunorubicin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.000386	0.171	CbGdCrCtD
Daunorubicin—TOP2B—thyroid gland—head and neck cancer	0.000384	0.0182	CbGeAlD
Daunorubicin—POR—trachea—head and neck cancer	0.000383	0.0182	CbGeAlD
Daunorubicin—ABCC6—head—head and neck cancer	0.000375	0.0178	CbGeAlD
Daunorubicin—Amnesia—Fluorouracil—head and neck cancer	0.000372	0.00407	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000367	0.00401	CcSEcCtD
Daunorubicin—Stomatitis—Hydroxyurea—head and neck cancer	0.000365	0.00399	CcSEcCtD
Daunorubicin—Cardiac failure—Fluorouracil—head and neck cancer	0.000358	0.00392	CcSEcCtD
Daunorubicin—YWHAG—head—head and neck cancer	0.000353	0.0168	CbGeAlD
Daunorubicin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00035	0.00382	CcSEcCtD
Daunorubicin—TOP2B—head—head and neck cancer	0.000341	0.0162	CbGeAlD
Daunorubicin—Influenza like illness—Docetaxel—head and neck cancer	0.000338	0.00369	CcSEcCtD
Daunorubicin—Hallucination—Hydroxyurea—head and neck cancer	0.000334	0.00366	CcSEcCtD
Daunorubicin—Cardiac arrest—Fluorouracil—head and neck cancer	0.000333	0.00364	CcSEcCtD
Daunorubicin—Ataxia—Fluorouracil—head and neck cancer	0.000329	0.0036	CcSEcCtD
Daunorubicin—CYP1A1—mouth—head and neck cancer	0.000328	0.0156	CbGeAlD
Daunorubicin—Neuropathy—Docetaxel—head and neck cancer	0.000327	0.00357	CcSEcCtD
Daunorubicin—Alopecia—Vinblastine—head and neck cancer	0.000326	0.00356	CcSEcCtD
Daunorubicin—Dry skin—Fluorouracil—head and neck cancer	0.000321	0.00351	CcSEcCtD
Daunorubicin—Oesophagitis—Docetaxel—head and neck cancer	0.000318	0.00347	CcSEcCtD
Daunorubicin—ABCC10—trachea—head and neck cancer	0.000304	0.0144	CbGeAlD
Daunorubicin—POR—thyroid gland—head and neck cancer	0.000303	0.0144	CbGeAlD
Daunorubicin—Dysphagia—Fluorouracil—head and neck cancer	0.000302	0.00331	CcSEcCtD
Daunorubicin—Chills—Hydroxyurea—head and neck cancer	0.000302	0.0033	CcSEcCtD
Daunorubicin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000298	0.00326	CcSEcCtD
Daunorubicin—Alopecia—Hydroxyurea—head and neck cancer	0.000297	0.00325	CcSEcCtD
Daunorubicin—Anaemia—Vinblastine—head and neck cancer	0.000297	0.00324	CcSEcCtD
Daunorubicin—Angina pectoris—Fluorouracil—head and neck cancer	0.000294	0.00322	CcSEcCtD
Daunorubicin—Erythema—Hydroxyurea—head and neck cancer	0.000293	0.0032	CcSEcCtD
Daunorubicin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000292	0.00319	CcSEcCtD
Daunorubicin—ABCC1—parotid gland—head and neck cancer	0.000291	0.0138	CbGeAlD
Daunorubicin—Malaise—Vinblastine—head and neck cancer	0.000289	0.00316	CcSEcCtD
Daunorubicin—Leukopenia—Vinblastine—head and neck cancer	0.000287	0.00314	CcSEcCtD
Daunorubicin—Pancytopenia—Fluorouracil—head and neck cancer	0.000287	0.00314	CcSEcCtD
Daunorubicin—CYP1B1—connective tissue—head and neck cancer	0.000285	0.0135	CbGeAlD
Daunorubicin—TOP2A—thyroid gland—head and neck cancer	0.000282	0.0134	CbGeAlD
Daunorubicin—Deafness—Docetaxel—head and neck cancer	0.000282	0.00309	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000278	0.00304	CcSEcCtD
Daunorubicin—Convulsion—Vinblastine—head and neck cancer	0.000278	0.00304	CcSEcCtD
Daunorubicin—Hypertension—Vinblastine—head and neck cancer	0.000277	0.00303	CcSEcCtD
Daunorubicin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000272	0.00297	CcSEcCtD
Daunorubicin—Anaemia—Hydroxyurea—head and neck cancer	0.00027	0.00296	CcSEcCtD
Daunorubicin—Discomfort—Vinblastine—head and neck cancer	0.00027	0.00295	CcSEcCtD
Daunorubicin—Hot flush—Docetaxel—head and neck cancer	0.00027	0.00295	CcSEcCtD
Daunorubicin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000268	0.00293	CcSEcCtD
Daunorubicin—Atrial fibrillation—Docetaxel—head and neck cancer	0.000266	0.00291	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000266	0.00291	CcSEcCtD
Daunorubicin—Renal impairment—Docetaxel—head and neck cancer	0.000265	0.0029	CcSEcCtD
Daunorubicin—ABCC10—lymphoid tissue—head and neck cancer	0.000265	0.0126	CbGeAlD
Daunorubicin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000264	0.00289	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000264	0.00289	CcSEcCtD
Daunorubicin—Malaise—Hydroxyurea—head and neck cancer	0.000264	0.00289	CcSEcCtD
Daunorubicin—Stomatitis—Fluorouracil—head and neck cancer	0.000263	0.00287	CcSEcCtD
Daunorubicin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000262	0.00286	CcSEcCtD
Daunorubicin—Leukopenia—Hydroxyurea—head and neck cancer	0.000262	0.00286	CcSEcCtD
Daunorubicin—Cardiac failure—Docetaxel—head and neck cancer	0.000259	0.00283	CcSEcCtD
Daunorubicin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000256	0.0028	CcSEcCtD
Daunorubicin—Convulsion—Hydroxyurea—head and neck cancer	0.000254	0.00277	CcSEcCtD
Daunorubicin—Sinusitis—Fluorouracil—head and neck cancer	0.000253	0.00277	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000252	0.00276	CcSEcCtD
Daunorubicin—Anorexia—Vinblastine—head and neck cancer	0.00025	0.00273	CcSEcCtD
Daunorubicin—YWHAG—lymph node—head and neck cancer	0.000248	0.0117	CbGeAlD
Daunorubicin—Discomfort—Hydroxyurea—head and neck cancer	0.000246	0.00269	CcSEcCtD
Daunorubicin—Rhinitis—Fluorouracil—head and neck cancer	0.000243	0.00265	CcSEcCtD
Daunorubicin—ABCG2—parotid gland—head and neck cancer	0.000241	0.0114	CbGeAlD
Daunorubicin—ABCC10—thyroid gland—head and neck cancer	0.00024	0.0114	CbGeAlD
Daunorubicin—Oedema—Hydroxyurea—head and neck cancer	0.000239	0.00261	CcSEcCtD
Daunorubicin—TOP2B—lymph node—head and neck cancer	0.000239	0.0113	CbGeAlD
Daunorubicin—Ataxia—Docetaxel—head and neck cancer	0.000237	0.0026	CcSEcCtD
Daunorubicin—Infection—Hydroxyurea—head and neck cancer	0.000237	0.00259	CcSEcCtD
Daunorubicin—Dehydration—Docetaxel—head and neck cancer	0.000235	0.00257	CcSEcCtD
Daunorubicin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000234	0.00256	CcSEcCtD
Daunorubicin—Dry skin—Docetaxel—head and neck cancer	0.000231	0.00253	CcSEcCtD
Daunorubicin—ABCG2—saliva-secreting gland—head and neck cancer	0.000231	0.0109	CbGeAlD
Daunorubicin—CYP1A1—parotid gland—head and neck cancer	0.000229	0.0108	CbGeAlD
Daunorubicin—Anorexia—Hydroxyurea—head and neck cancer	0.000228	0.00249	CcSEcCtD
Daunorubicin—Decreased appetite—Vinblastine—head and neck cancer	0.000228	0.00249	CcSEcCtD
Daunorubicin—Constipation—Vinblastine—head and neck cancer	0.000224	0.00245	CcSEcCtD
Daunorubicin—Pain—Vinblastine—head and neck cancer	0.000224	0.00245	CcSEcCtD
Daunorubicin—Dysphagia—Docetaxel—head and neck cancer	0.000218	0.00239	CcSEcCtD
Daunorubicin—Arrhythmia—Fluorouracil—head and neck cancer	0.000216	0.00236	CcSEcCtD
Daunorubicin—Feeling abnormal—Vinblastine—head and neck cancer	0.000216	0.00236	CcSEcCtD
Daunorubicin—ABCC1—trachea—head and neck cancer	0.000215	0.0102	CbGeAlD
Daunorubicin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000214	0.00234	CcSEcCtD
Daunorubicin—Alopecia—Fluorouracil—head and neck cancer	0.000214	0.00234	CcSEcCtD
Daunorubicin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000213	0.00233	CcSEcCtD
Daunorubicin—Angina pectoris—Docetaxel—head and neck cancer	0.000213	0.00232	CcSEcCtD
Daunorubicin—Somnolence—Hydroxyurea—head and neck cancer	0.000212	0.00232	CcSEcCtD
Daunorubicin—Erythema—Fluorouracil—head and neck cancer	0.000211	0.0023	CcSEcCtD
Daunorubicin—CYP1B1—lymphoid tissue—head and neck cancer	0.000208	0.00987	CbGeAlD
Daunorubicin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000208	0.00227	CcSEcCtD
Daunorubicin—Pancytopenia—Docetaxel—head and neck cancer	0.000207	0.00227	CcSEcCtD
Daunorubicin—Abdominal pain—Vinblastine—head and neck cancer	0.000207	0.00226	CcSEcCtD
Daunorubicin—Fatigue—Hydroxyurea—head and neck cancer	0.000206	0.00225	CcSEcCtD
Daunorubicin—Pain—Hydroxyurea—head and neck cancer	0.000204	0.00223	CcSEcCtD
Daunorubicin—Constipation—Hydroxyurea—head and neck cancer	0.000204	0.00223	CcSEcCtD
Daunorubicin—Neutropenia—Docetaxel—head and neck cancer	0.000204	0.00223	CcSEcCtD
Daunorubicin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000197	0.00215	CcSEcCtD
Daunorubicin—Anaemia—Fluorouracil—head and neck cancer	0.000195	0.00213	CcSEcCtD
Daunorubicin—Hypersensitivity—Vinblastine—head and neck cancer	0.000193	0.00211	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000192	0.0021	CcSEcCtD
Daunorubicin—Renal failure—Docetaxel—head and neck cancer	0.000191	0.00209	CcSEcCtD
Daunorubicin—CYP1A1—epithelium—head and neck cancer	0.000191	0.00906	CbGeAlD
Daunorubicin—Myocardial infarction—Docetaxel—head and neck cancer	0.000191	0.00209	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000191	0.00209	CcSEcCtD
Daunorubicin—Stomatitis—Docetaxel—head and neck cancer	0.00019	0.00207	CcSEcCtD
Daunorubicin—Conjunctivitis—Docetaxel—head and neck cancer	0.000189	0.00207	CcSEcCtD
Daunorubicin—CYP1B1—thyroid gland—head and neck cancer	0.000189	0.00897	CbGeAlD
Daunorubicin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000189	0.00206	CcSEcCtD
Daunorubicin—Leukopenia—Fluorouracil—head and neck cancer	0.000189	0.00206	CcSEcCtD
Daunorubicin—POR—lymph node—head and neck cancer	0.000188	0.00893	CbGeAlD
Daunorubicin—Asthenia—Vinblastine—head and neck cancer	0.000188	0.00205	CcSEcCtD
Daunorubicin—Convulsion—Fluorouracil—head and neck cancer	0.000182	0.002	CcSEcCtD
Daunorubicin—Myalgia—Fluorouracil—head and neck cancer	0.000179	0.00196	CcSEcCtD
Daunorubicin—Chest pain—Fluorouracil—head and neck cancer	0.000179	0.00196	CcSEcCtD
Daunorubicin—Diarrhoea—Vinblastine—head and neck cancer	0.000179	0.00196	CcSEcCtD
Daunorubicin—Discomfort—Fluorouracil—head and neck cancer	0.000177	0.00194	CcSEcCtD
Daunorubicin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000176	0.00192	CcSEcCtD
Daunorubicin—TOP2A—lymph node—head and neck cancer	0.000175	0.00832	CbGeAlD
Daunorubicin—Rhinitis—Docetaxel—head and neck cancer	0.000175	0.00191	CcSEcCtD
Daunorubicin—Confusional state—Fluorouracil—head and neck cancer	0.000173	0.0019	CcSEcCtD
Daunorubicin—Dizziness—Vinblastine—head and neck cancer	0.000173	0.00189	CcSEcCtD
Daunorubicin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000172	0.00188	CcSEcCtD
Daunorubicin—Oedema—Fluorouracil—head and neck cancer	0.000172	0.00188	CcSEcCtD
Daunorubicin—Asthenia—Hydroxyurea—head and neck cancer	0.000171	0.00187	CcSEcCtD
Daunorubicin—Infection—Fluorouracil—head and neck cancer	0.000171	0.00187	CcSEcCtD
Daunorubicin—ABCC1—thyroid gland—head and neck cancer	0.00017	0.00807	CbGeAlD
Daunorubicin—CYP1A1—trachea—head and neck cancer	0.000169	0.00801	CbGeAlD
Daunorubicin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000168	0.00184	CcSEcCtD
Daunorubicin—Visual impairment—Docetaxel—head and neck cancer	0.000168	0.00184	CcSEcCtD
Daunorubicin—Tachycardia—Fluorouracil—head and neck cancer	0.000168	0.00183	CcSEcCtD
Daunorubicin—CYP1B1—head—head and neck cancer	0.000168	0.00796	CbGeAlD
Daunorubicin—Vomiting—Vinblastine—head and neck cancer	0.000167	0.00182	CcSEcCtD
Daunorubicin—Headache—Vinblastine—head and neck cancer	0.000164	0.00179	CcSEcCtD
Daunorubicin—Anorexia—Fluorouracil—head and neck cancer	0.000164	0.00179	CcSEcCtD
Daunorubicin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000163	0.00179	CcSEcCtD
Daunorubicin—Flushing—Docetaxel—head and neck cancer	0.000162	0.00177	CcSEcCtD
Daunorubicin—Cardiac disorder—Docetaxel—head and neck cancer	0.000162	0.00177	CcSEcCtD
Daunorubicin—Dizziness—Hydroxyurea—head and neck cancer	0.000158	0.00173	CcSEcCtD
Daunorubicin—Chills—Docetaxel—head and neck cancer	0.000157	0.00171	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000157	0.00171	CcSEcCtD
Daunorubicin—Arrhythmia—Docetaxel—head and neck cancer	0.000156	0.00171	CcSEcCtD
Daunorubicin—Nausea—Vinblastine—head and neck cancer	0.000156	0.0017	CcSEcCtD
Daunorubicin—Insomnia—Fluorouracil—head and neck cancer	0.000155	0.0017	CcSEcCtD
Daunorubicin—Alopecia—Docetaxel—head and neck cancer	0.000154	0.00169	CcSEcCtD
Daunorubicin—Dyspnoea—Fluorouracil—head and neck cancer	0.000153	0.00168	CcSEcCtD
Daunorubicin—Somnolence—Fluorouracil—head and neck cancer	0.000153	0.00167	CcSEcCtD
Daunorubicin—Erythema—Docetaxel—head and neck cancer	0.000152	0.00166	CcSEcCtD
Daunorubicin—Vomiting—Hydroxyurea—head and neck cancer	0.000152	0.00166	CcSEcCtD
Daunorubicin—Rash—Hydroxyurea—head and neck cancer	0.000151	0.00165	CcSEcCtD
Daunorubicin—Dermatitis—Hydroxyurea—head and neck cancer	0.00015	0.00165	CcSEcCtD
Daunorubicin—Headache—Hydroxyurea—head and neck cancer	0.00015	0.00164	CcSEcCtD
Daunorubicin—Decreased appetite—Fluorouracil—head and neck cancer	0.000149	0.00163	CcSEcCtD
Daunorubicin—ABCC10—lymph node—head and neck cancer	0.000149	0.00708	CbGeAlD
Daunorubicin—Dysgeusia—Docetaxel—head and neck cancer	0.000149	0.00163	CcSEcCtD
Daunorubicin—Back pain—Docetaxel—head and neck cancer	0.000147	0.00161	CcSEcCtD
Daunorubicin—Pain—Fluorouracil—head and neck cancer	0.000147	0.00161	CcSEcCtD
Daunorubicin—Nausea—Hydroxyurea—head and neck cancer	0.000142	0.00155	CcSEcCtD
Daunorubicin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000142	0.00155	CcSEcCtD
Daunorubicin—ABCG2—thyroid gland—head and neck cancer	0.000141	0.00668	CbGeAlD
Daunorubicin—Anaemia—Docetaxel—head and neck cancer	0.000141	0.00154	CcSEcCtD
Daunorubicin—Urticaria—Fluorouracil—head and neck cancer	0.000137	0.00149	CcSEcCtD
Daunorubicin—Syncope—Docetaxel—head and neck cancer	0.000136	0.00149	CcSEcCtD
Daunorubicin—Leukopenia—Docetaxel—head and neck cancer	0.000136	0.00149	CcSEcCtD
Daunorubicin—Body temperature increased—Fluorouracil—head and neck cancer	0.000136	0.00149	CcSEcCtD
Daunorubicin—CYP1A2—thyroid gland—head and neck cancer	0.000135	0.00643	CbGeAlD
Daunorubicin—Palpitations—Docetaxel—head and neck cancer	0.000134	0.00147	CcSEcCtD
Daunorubicin—Loss of consciousness—Docetaxel—head and neck cancer	0.000134	0.00146	CcSEcCtD
Daunorubicin—CYP1A1—thyroid gland—head and neck cancer	0.000134	0.00634	CbGeAlD
Daunorubicin—Cough—Docetaxel—head and neck cancer	0.000133	0.00145	CcSEcCtD
Daunorubicin—Convulsion—Docetaxel—head and neck cancer	0.000132	0.00144	CcSEcCtD
Daunorubicin—Hypertension—Docetaxel—head and neck cancer	0.000131	0.00144	CcSEcCtD
Daunorubicin—Myalgia—Docetaxel—head and neck cancer	0.000129	0.00142	CcSEcCtD
Daunorubicin—Arthralgia—Docetaxel—head and neck cancer	0.000129	0.00142	CcSEcCtD
Daunorubicin—Chest pain—Docetaxel—head and neck cancer	0.000129	0.00142	CcSEcCtD
Daunorubicin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000127	0.00138	CcSEcCtD
Daunorubicin—Dry mouth—Docetaxel—head and neck cancer	0.000127	0.00138	CcSEcCtD
Daunorubicin—Confusional state—Docetaxel—head and neck cancer	0.000125	0.00137	CcSEcCtD
Daunorubicin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000124	0.00136	CcSEcCtD
Daunorubicin—Oedema—Docetaxel—head and neck cancer	0.000124	0.00136	CcSEcCtD
Daunorubicin—Infection—Docetaxel—head and neck cancer	0.000123	0.00135	CcSEcCtD
Daunorubicin—Shock—Docetaxel—head and neck cancer	0.000122	0.00133	CcSEcCtD
Daunorubicin—Pruritus—Fluorouracil—head and neck cancer	0.000122	0.00133	CcSEcCtD
Daunorubicin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000121	0.00133	CcSEcCtD
Daunorubicin—Tachycardia—Docetaxel—head and neck cancer	0.000121	0.00132	CcSEcCtD
Daunorubicin—ABCC2—lymph node—head and neck cancer	0.00012	0.00569	CbGeAlD
Daunorubicin—CYP1A1—head—head and neck cancer	0.000119	0.00562	CbGeAlD
Daunorubicin—Anorexia—Docetaxel—head and neck cancer	0.000118	0.00129	CcSEcCtD
Daunorubicin—Diarrhoea—Fluorouracil—head and neck cancer	0.000118	0.00129	CcSEcCtD
Daunorubicin—CYP1B1—lymph node—head and neck cancer	0.000117	0.00557	CbGeAlD
Daunorubicin—Dizziness—Fluorouracil—head and neck cancer	0.000114	0.00124	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000113	0.00124	CcSEcCtD
Daunorubicin—Insomnia—Docetaxel—head and neck cancer	0.000112	0.00123	CcSEcCtD
Daunorubicin—Dyspnoea—Docetaxel—head and neck cancer	0.000111	0.00121	CcSEcCtD
Daunorubicin—Somnolence—Docetaxel—head and neck cancer	0.00011	0.00121	CcSEcCtD
Daunorubicin—Vomiting—Fluorouracil—head and neck cancer	0.000109	0.0012	CcSEcCtD
Daunorubicin—Rash—Fluorouracil—head and neck cancer	0.000108	0.00119	CcSEcCtD
Daunorubicin—Dermatitis—Fluorouracil—head and neck cancer	0.000108	0.00118	CcSEcCtD
Daunorubicin—Decreased appetite—Docetaxel—head and neck cancer	0.000108	0.00118	CcSEcCtD
Daunorubicin—Headache—Fluorouracil—head and neck cancer	0.000108	0.00118	CcSEcCtD
Daunorubicin—Fatigue—Docetaxel—head and neck cancer	0.000107	0.00117	CcSEcCtD
Daunorubicin—Constipation—Docetaxel—head and neck cancer	0.000106	0.00116	CcSEcCtD
Daunorubicin—Pain—Docetaxel—head and neck cancer	0.000106	0.00116	CcSEcCtD
Daunorubicin—ABCC1—lymph node—head and neck cancer	0.000106	0.00501	CbGeAlD
Daunorubicin—Feeling abnormal—Docetaxel—head and neck cancer	0.000102	0.00112	CcSEcCtD
Daunorubicin—Nausea—Fluorouracil—head and neck cancer	0.000102	0.00112	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000101	0.00111	CcSEcCtD
Daunorubicin—ABCB1—epithelium—head and neck cancer	9.92e-05	0.00471	CbGeAlD
Daunorubicin—Body temperature increased—Docetaxel—head and neck cancer	9.81e-05	0.00107	CcSEcCtD
Daunorubicin—Abdominal pain—Docetaxel—head and neck cancer	9.81e-05	0.00107	CcSEcCtD
Daunorubicin—Hypersensitivity—Docetaxel—head and neck cancer	9.14e-05	0.001	CcSEcCtD
Daunorubicin—Asthenia—Docetaxel—head and neck cancer	8.9e-05	0.000973	CcSEcCtD
Daunorubicin—Pruritus—Docetaxel—head and neck cancer	8.78e-05	0.00096	CcSEcCtD
Daunorubicin—ABCB1—trachea—head and neck cancer	8.77e-05	0.00416	CbGeAlD
Daunorubicin—ABCG2—lymph node—head and neck cancer	8.74e-05	0.00415	CbGeAlD
Daunorubicin—Diarrhoea—Docetaxel—head and neck cancer	8.49e-05	0.000928	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—head and neck cancer	8.3e-05	0.00394	CbGeAlD
Daunorubicin—Dizziness—Docetaxel—head and neck cancer	8.2e-05	0.000897	CcSEcCtD
Daunorubicin—Vomiting—Docetaxel—head and neck cancer	7.89e-05	0.000863	CcSEcCtD
Daunorubicin—Rash—Docetaxel—head and neck cancer	7.82e-05	0.000855	CcSEcCtD
Daunorubicin—Dermatitis—Docetaxel—head and neck cancer	7.82e-05	0.000855	CcSEcCtD
Daunorubicin—Headache—Docetaxel—head and neck cancer	7.77e-05	0.00085	CcSEcCtD
Daunorubicin—ABCB1—lymphoid tissue—head and neck cancer	7.64e-05	0.00363	CbGeAlD
Daunorubicin—Nausea—Docetaxel—head and neck cancer	7.37e-05	0.000806	CcSEcCtD
Daunorubicin—ABCB1—thyroid gland—head and neck cancer	6.94e-05	0.00329	CbGeAlD
Daunorubicin—ABCB1—head—head and neck cancer	6.16e-05	0.00292	CbGeAlD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	4.49e-05	0.000863	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	4.48e-05	0.000861	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.47e-05	0.000858	CbGpPWpGaD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.46e-05	0.000855	CbGpPWpGaD
Daunorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.4e-05	0.000844	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—AKT1—head and neck cancer	4.39e-05	0.000843	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MAPK1—head and neck cancer	4.39e-05	0.000842	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—head and neck cancer	4.39e-05	0.000842	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	4.35e-05	0.000836	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	4.33e-05	0.000831	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.32e-05	0.00083	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—NAT2—head and neck cancer	4.32e-05	0.000829	CbGpPWpGaD
Daunorubicin—ABCB1—lymph node—head and neck cancer	4.31e-05	0.00205	CbGeAlD
Daunorubicin—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	4.29e-05	0.000824	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—NOTCH1—head and neck cancer	4.26e-05	0.000819	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	4.25e-05	0.000815	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	4.23e-05	0.000813	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	4.13e-05	0.000792	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	4.11e-05	0.00079	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	4.1e-05	0.000787	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.07e-05	0.000782	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	4.07e-05	0.000781	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	4.06e-05	0.000779	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	4.04e-05	0.000776	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TYMS—head and neck cancer	4.02e-05	0.000771	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.97e-05	0.000763	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	3.94e-05	0.000756	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.85e-05	0.00074	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.79e-05	0.000728	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—DPYD—head and neck cancer	3.79e-05	0.000727	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—AKT1—head and neck cancer	3.73e-05	0.000717	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.7e-05	0.000711	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.67e-05	0.000704	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.67e-05	0.000704	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—UROD—head and neck cancer	3.63e-05	0.000697	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.61e-05	0.000693	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—YAP1—head and neck cancer	3.59e-05	0.00069	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HRAS—head and neck cancer	3.52e-05	0.000676	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—UROD—head and neck cancer	3.43e-05	0.000658	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.38e-05	0.000649	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.35e-05	0.000642	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	3.35e-05	0.000642	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.23e-05	0.000621	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2—head and neck cancer	3.2e-05	0.000614	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NAT2—head and neck cancer	3.18e-05	0.000611	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.18e-05	0.000611	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.14e-05	0.000603	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—AKT1—head and neck cancer	3.11e-05	0.000597	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.08e-05	0.000591	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.07e-05	0.00059	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.06e-05	0.000587	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	3.01e-05	0.000578	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	3.01e-05	0.000578	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	3.01e-05	0.000578	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	2.96e-05	0.000567	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—head and neck cancer	2.89e-05	0.000555	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—DPYD—head and neck cancer	2.79e-05	0.000536	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—UROD—head and neck cancer	2.74e-05	0.000526	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.72e-05	0.000522	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.67e-05	0.000512	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.66e-05	0.000511	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—YAP1—head and neck cancer	2.65e-05	0.000508	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.62e-05	0.000503	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.6e-05	0.000499	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.59e-05	0.000497	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.54e-05	0.000488	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.54e-05	0.000487	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.51e-05	0.000483	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.49e-05	0.000477	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.46e-05	0.000472	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.45e-05	0.000471	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.43e-05	0.000467	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.42e-05	0.000464	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NAT2—head and neck cancer	2.39e-05	0.000459	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MAPK3—head and neck cancer	2.39e-05	0.000458	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MAPK3—head and neck cancer	2.36e-05	0.000453	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NAT2—head and neck cancer	2.31e-05	0.000444	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MAPK1—head and neck cancer	2.27e-05	0.000436	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.26e-05	0.000434	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—UROD—head and neck cancer	2.19e-05	0.00042	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TYMS—head and neck cancer	2.16e-05	0.000414	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.000409	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	2.13e-05	0.000409	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NAT2—head and neck cancer	2.1e-05	0.000404	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—DPYD—head and neck cancer	2.1e-05	0.000403	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.09e-05	0.000401	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NAT2—head and neck cancer	2.08e-05	0.0004	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000392	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—DPYD—head and neck cancer	2.03e-05	0.000389	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.02e-05	0.000389	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—head and neck cancer	2.02e-05	0.000388	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000388	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2e-05	0.000385	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2e-05	0.000383	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.99e-05	0.000382	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—YAP1—head and neck cancer	1.99e-05	0.000382	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—YAP1—head and neck cancer	1.92e-05	0.000369	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.92e-05	0.000368	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—head and neck cancer	1.91e-05	0.000366	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.89e-05	0.000363	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.87e-05	0.000358	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DPYD—head and neck cancer	1.84e-05	0.000354	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DPYD—head and neck cancer	1.83e-05	0.000351	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.79e-05	0.000344	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.78e-05	0.000341	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—YAP1—head and neck cancer	1.75e-05	0.000336	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.74e-05	0.000333	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—YAP1—head and neck cancer	1.73e-05	0.000333	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.71e-05	0.000328	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.7e-05	0.000327	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.7e-05	0.000326	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—UROD—head and neck cancer	1.69e-05	0.000324	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	1.67e-05	0.00032	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MAPK1—head and neck cancer	1.63e-05	0.000313	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—head and neck cancer	1.59e-05	0.000305	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TYMS—head and neck cancer	1.59e-05	0.000305	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	1.59e-05	0.000305	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTM1—head and neck cancer	1.57e-05	0.000302	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.54e-05	0.000295	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.51e-05	0.00029	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NAT2—head and neck cancer	1.51e-05	0.000289	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GPX1—head and neck cancer	1.51e-05	0.000289	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.49e-05	0.000287	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1A1—head and neck cancer	1.49e-05	0.000286	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.49e-05	0.000285	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.45e-05	0.000278	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NAT2—head and neck cancer	1.42e-05	0.000273	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.34e-05	0.000258	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—head and neck cancer	1.33e-05	0.000256	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DPYD—head and neck cancer	1.32e-05	0.000254	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—head and neck cancer	1.31e-05	0.000252	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.3e-05	0.00025	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.27e-05	0.000244	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.26e-05	0.000242	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—YAP1—head and neck cancer	1.25e-05	0.000241	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DPYD—head and neck cancer	1.25e-05	0.00024	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.22e-05	0.000235	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.21e-05	0.000232	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.21e-05	0.000232	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000231	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TYMS—head and neck cancer	1.19e-05	0.000229	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—YAP1—head and neck cancer	1.19e-05	0.000228	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTM1—head and neck cancer	1.18e-05	0.000227	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TYMS—head and neck cancer	1.16e-05	0.000222	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTM1—head and neck cancer	1.14e-05	0.000219	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NAT2—head and neck cancer	1.14e-05	0.000218	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GPX1—head and neck cancer	1.13e-05	0.000217	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.12e-05	0.000215	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GPX1—head and neck cancer	1.09e-05	0.00021	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A1—head and neck cancer	1.08e-05	0.000208	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOTCH1—head and neck cancer	1.07e-05	0.000206	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TYMS—head and neck cancer	1.05e-05	0.000202	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000201	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.05e-05	0.000201	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TYMS—head and neck cancer	1.04e-05	0.0002	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTM1—head and neck cancer	1.04e-05	0.000199	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.03e-05	0.000197	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.01e-05	0.000195	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DPYD—head and neck cancer	9.97e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GPX1—head and neck cancer	9.95e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A1—head and neck cancer	9.85e-06	0.000189	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GPX1—head and neck cancer	9.85e-06	0.000189	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A1—head and neck cancer	9.75e-06	0.000187	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.64e-06	0.000185	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.55e-06	0.000183	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—YAP1—head and neck cancer	9.47e-06	0.000182	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.2e-06	0.000177	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NAT2—head and neck cancer	9.08e-06	0.000174	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.9e-06	0.000171	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.9e-06	0.000171	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—head and neck cancer	8.86e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.56e-06	0.000164	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DPYD—head and neck cancer	7.96e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—head and neck cancer	7.95e-06	0.000153	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.77e-06	0.000149	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—head and neck cancer	7.73e-06	0.000148	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—YAP1—head and neck cancer	7.56e-06	0.000145	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—head and neck cancer	7.53e-06	0.000145	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—head and neck cancer	7.45e-06	0.000143	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—head and neck cancer	7.4e-06	0.000142	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX1—head and neck cancer	7.13e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—head and neck cancer	7.12e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—head and neck cancer	7.06e-06	0.000136	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—head and neck cancer	7.03e-06	0.000135	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAT2—head and neck cancer	7.01e-06	0.000135	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—head and neck cancer	6.93e-06	0.000133	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX1—head and neck cancer	6.74e-06	0.000129	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—head and neck cancer	6.66e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—head and neck cancer	6.44e-06	0.000124	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—head and neck cancer	6.2e-06	0.000119	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DPYD—head and neck cancer	6.15e-06	0.000118	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—head and neck cancer	6.04e-06	0.000116	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK3—head and neck cancer	5.92e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—head and neck cancer	5.86e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—YAP1—head and neck cancer	5.83e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—head and neck cancer	5.81e-06	0.000111	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—head and neck cancer	5.8e-06	0.000111	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—head and neck cancer	5.68e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.68e-06	0.000109	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK1—head and neck cancer	5.64e-06	0.000108	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—head and neck cancer	5.64e-06	0.000108	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—head and neck cancer	5.62e-06	0.000108	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—head and neck cancer	5.62e-06	0.000108	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.48e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—head and neck cancer	5.45e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX1—head and neck cancer	5.38e-06	0.000103	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.33e-06	0.000102	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—head and neck cancer	5.11e-06	9.81e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—head and neck cancer	5.06e-06	9.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.95e-06	9.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—head and neck cancer	4.89e-06	9.39e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—head and neck cancer	4.54e-06	8.71e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—head and neck cancer	4.53e-06	8.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—head and neck cancer	4.49e-06	8.61e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—head and neck cancer	4.45e-06	8.55e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX1—head and neck cancer	4.3e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	4.25e-06	8.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.2e-06	8.06e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.1e-06	7.86e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—head and neck cancer	4e-06	7.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—head and neck cancer	3.97e-06	7.61e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—head and neck cancer	3.96e-06	7.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—head and neck cancer	3.66e-06	7.03e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—head and neck cancer	3.6e-06	6.92e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—head and neck cancer	3.57e-06	6.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—head and neck cancer	3.5e-06	6.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.49e-06	6.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.46e-06	6.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—head and neck cancer	3.46e-06	6.64e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—head and neck cancer	3.35e-06	6.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX1—head and neck cancer	3.31e-06	6.36e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.28e-06	6.3e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—head and neck cancer	3.24e-06	6.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—head and neck cancer	3.17e-06	6.08e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—head and neck cancer	2.94e-06	5.65e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—head and neck cancer	2.91e-06	5.59e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—head and neck cancer	2.76e-06	5.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.58e-06	4.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.53e-06	4.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.44e-06	4.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—head and neck cancer	2.21e-06	4.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—head and neck cancer	2.11e-06	4.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—head and neck cancer	1.99e-06	3.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.95e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.95e-06	3.74e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—head and neck cancer	1.7e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—head and neck cancer	1.59e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.56e-06	2.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.27e-06	2.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.2e-06	2.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—head and neck cancer	9.81e-07	1.88e-05	CbGpPWpGaD
